Members are planning televised hearings and reports that will bring their findings out into the open.
Erica Nitschke
Columnist
Schools adapt for return from break as COVID-19 cases surge
The return from schools’ winter break will be different than planned for some.
New easy-to-use COVID-19 pills come with a catch
The challenge is getting tested, getting a prescription and starting the pills in a short window.
Federal program offers cash to cover costs of funeral due to COVID-19
Families who have lost loved ones to COVID-19 can apply for reimbursement from the federal government for up to $9,000 to cover the cost of funeral expenses.
Despite supply issues and omicron, holiday sales rise 8.5%
Holiday sales were up 10.7 percent compared with the pre-pandemic 2019 holiday period.
Preliminary data from U.K. suggests hospitalization less likely with omicron
Britain’s public health agency says preliminary data suggests that people with the omicron variant of the coronavirus are 50 to 70 percent less likely to be hospitalized than those with the delta strain.
To grandmother’s house or no? Omicron disrupts holiday plans
For the second year in a row, the ever-morphing coronavirus presents would-be holiday revelers with a difficult choice: cancel their trips and celebrations yet again or figure out how to forge ahead as safely as possible.
U.S. has reunited 100 children taken from parents under Trump
President Biden issued an executive order on his first day in office to reunite families that were forcibly separated at the U.S.-Mexico border to discourage illegal immigration.
Another danger to illicit drug users: Animal tranquilizer
An animal sedative, xylazine, is making its way into the drug supply, particularly in the Northeast.
Markets 2021: Stocks soar, IPOs explode, crypto goes wild
Skyrocketing inflation, worldwide supply-chain disruptions and a global economy still vulnerable to the uncertainty created by the COVID-19 pandemic fueled market volatility, especially toward the end of the year.